IONS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Ionis Pharmaceuticals (IONS) Earnings Date & Reports

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IONS is expected to report earnings to rise 66.67% to -110 cents per share on April 30

Ionis Pharmaceuticals IONS Stock Earnings Reports

Q1'25

Est.

$-1.10

Q4'24

Beat

by $0.45

Q3'24

Beat

by $0.17

Q2'24

Beat

by $0.48

Q1'24

Beat

by $0.05

The last earnings report on February 19 showed earnings per share of -66 cents, beating the estimate of -111 cents. With 995.78K shares outstanding, the current market capitalization sits at 5.37B.

View a ticker or compare two or three

Compare

IONS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IONS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for IONS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of antisense drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2855 Gazelle Court

Phone

+1 760 931-9200

Employees

927

Web

https://www.ionispharma.com